Is Your Company Ready for the 21st Century Cures Act?

As most biopharmaceutical groups are aware, the 21st Century Cures Act of 2016 mandates a number of powerful core changes to drug and medical device development timelines. ...
Read More

5 Key Trends Shaping the Future of Drug Development

The FDA’s Center for Drug Evaluation and Research (CDER) offers an all-encompassing bundle of information that is of interest to the pharmaceutical industry to help get their ...
Read More